Physician profile
Michael J Henry
NPI 1689644817
$5,468.13
in general payments reported to CMS, 2019-2025
17 companies · $2,748 in 2025
The $2,748 reported for 2025 was more than what 91% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $757 · 2020: $140 · 2021: $215 · 2022: $220 · 2023: $671 · 2024: $717 · 2025: $2,748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,186 · Consulting Fee: $1,950.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,185.84 |
| Consulting Fee | $1,950.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $2,900.40 | 2019-2025 | Idosetr, Photrexa Cross-Linking Kit, Kxl System (Not Refurbished) |
| Alcon Vision LLC | $1,054.10 | 2019-2025 | Clareon, Rocklatan, Lensx |
| Amgen INC. | $208.04 | 2024-2025 | Tepezza |
| Bausch & Lomb Americas INC. | $172.02 | 2024-2025 | Miebo, Xiidra, Vyzulta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $160.97 | 2019-2021 | |
| Rxsight INC | $143.46 | 2023 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Light Delivery Device (Ldd) |
| Biotissue Holdings INC. | $143.38 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $127.57 | 2019 | |
| Omeros Corporation | $121.96 | 2019-2021 | |
| Sight Sciences, INC. | $118.60 | 2022 | |
| Novartis Pharmaceuticals Corporation | $107.36 | 2019-2022 | |
| Rayner Intraocular Lenses Limited | $65.65 | 2022-2023 | Omidria, Rayone Aspheric, Rayone Emv |
| Mallinckrodt Hospital Products INC. | $53.04 | 2025 | Acthar |
| Tarsus Pharmaceuticals, INC. | $34.04 | 2024 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $22.80 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Oyster Point Pharma, INC. | $15.34 | 2023 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.